Skip to main content
ASRAFALL25 Main banner
Icon Legend
Presentation Icons
Ticket Required
Ticket Required

ePosters

(EXP-07) - Exhibit Hall ePosters - Screen 08

Herpes Zoster Ophthalmicus Postherpetic Neuralgia Refractory to Pharmacotherapy Successfully Treated by Stellate Ganglion Blockade

Saturday, November 15, 2025
10:32 AM - 10:40 AM CT
Location: Griffin Hall - Screen 08
Introduction:

Herpes zoster ophthalmicus (HZO) is a shingles outbreak in the V1 distribution; complications may manifest as orbital inflammation, ophthalmoplegia, and photophobia, which may be unresponsive to conventional therapies. Ashikawa et al. describe resolution of severe HZO-associated oculomotor dysfunction following stellate ganglion laser (SGL) irradiation.1 Others suggest that stellate ganglion block (SGB) may benefit patients with trigeminal postherpetic neuralgia (PHN).2-5 We add to limited literature with a case of complete PHN resolution after SGB.

    Submitting Author(s)

  • CG

    Carol Girgiss, MD

    Resident
    Cedars Sinai Medical Sinai
    Oceanside, California, United States

    • Co-Author(s)

  • GL

    Gene Lee, M.D.

    Assistant Professor of Anesthesiology and Pain Medicine
    Cedars-Sinai Medical Center, United States